Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Mullen (MULN) Stock Heats Up as Cost to Borrow Rises

By Josh Enomoto, InvestorPlace Contributor

Although some evidence of a brewing short-squeeze excited Mullen believers, prospective traders must be cautious with MULN stock.

7 Undervalued Biotech Stocks to Buy Before They Boom

By Josh Enomoto, InvestorPlace Contributor

While medical innovations offer tremendous appeal, investors can still get a discount in this sector via undervalued biotech stocks to buy.

The 7 Biggest Opportunities for Stock Investors in 2023

By Josh Enomoto, InvestorPlace Contributor

Although the outgoing year presented much pain, it opened doors for the biggest opportunities for stock investors in 2023.

Why Is LightJump Acquisition (LJAQ) Stock Trending Today?

By Josh Enomoto, InvestorPlace Contributor

Although LightJump Acquisition’s merger announcement with Moolec Science drew early excitement, LJAQ stock quickly tumbled on viability concerns.

The 7 Best Mid-Cap Stocks to Buy Right Now

By Josh Enomoto, InvestorPlace Contributor

Those wanting growth potential without the stuffiness of the blue chips should consider the best mid-cap stocks to buy.

Load More